From 1-5 February, 2000 life science executives will be logging on for a week’s worth of free-to-watch executive level content. Sessions include live and on-demand presentations, panels, fireside chats and showcases from industry leading stakeholders within the biotech, medtech and healthtech sectors.

With 3-days of sector-specific content, alongside informal networking opportunities, there’s over 60hrs of intelligence and best practice that could make the difference to your 2021.

Whether you’re focused on learning about Drug Discovery / Product Development, Clinical Progression, Market / Regulatory Approval, Product Launch / Channel Strategies, Business Resilience, Fundraising, Deal Making or Strategic Exits, there are key content features for you.

Agenda and Speakers.

Here’s a brief glimpse of some sessions being delivered on Day 1 of the main agenda:

• China and beyond – Asian investment in innovation
• Corporate clout in Biotech ventures
• Making history with the biotech listing boom – KSFs and virtual roadshows
• Investing in infectious disease – how will the COVID pandemic transform the development, commercialisation, and partnering landscape?
• Investment in the pandemic era – evolving strategies or masking established fundamentals?
• Patient-centric approaches in Medtech
• Delivering scale and value through collaboration and partnerships
• The role of product design in successful Medtech commercialisation
• Pharma Is Investing In Healthcare’s Future
• Drug Discovery And Development In The Era Of AI And Analytics
• Digital Therapeutics – Creating And Commercialising Clinically-Validated Innovation
• Turning Pharma Into Digital-First Organisations

All sessions can be accessed for free when selection Content Only pass at registration.